Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012

Filetype[PDF-524.72 KB]


English

Details:

  • Alternative Title:
    J Pediatric Infect Dis Soc
  • Personal Author:
  • Description:
    Background

    Although the 1-dose varicella vaccination program, introduced in 1996, has led to significant declines in varicella disease, outbreaks continued to occur which led to the adoption of a 2-dose vaccination program in 2007. We previously reported an 88% decline in varicella-related hospitalizations and 59% decline in outpatient visits during 1994–2002. We now update data on varicella health care utilization with 10 years of additional data, during a period of stabilizing first-dose coverage and rapidly-increasing second dose coverage.

    Methods

    We performed a retrospective cohort study using claims data from 1994–2012 Truven Health MarketScan® databases. We examined trends in rates of varicella-related outpatient visits and hospitalizations for MarketScan enrollees aged 0–49 years, including outpatient laboratory testing, outpatient antiviral use and pediatric strokes, with 1994–1995 as the pre-vaccination period and 2006–2012 as the 2-dose varicella vaccination period.

    Results

    Varicella outpatient visits declined 84% in 2012 versus the pre-vaccination period, with a 60% decline during the 2-dose period. Varicella hospitalizations declined 93% in 2012 versus the pre-vaccination period, with a 38% decline during the 2-dose period. The proportion of those with a varicella outpatient visit having varicella laboratory testing increased from 6% in 2003 to 17% in 2012. There were 21,445 (17%) with a claim for antivirals, which was relatively stable over time. There was no reduction in pediatric strokes during 1994–2012.

    Conclusion

    We document from our large study population that the varicella vaccination program has led to significant declines in outpatient visits and hospitalizations from the pre-vaccination period through 2012, with additional declines during the 2-dose varicella vaccination period.

  • Subjects:
  • Source:
  • Pubmed ID:
    26407276
  • Pubmed Central ID:
    PMC4752432
  • Document Type:
  • Funding:
  • Place as Subject:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov